Compile Data Set for Download or QSAR
Report error Found 216 of affinity data for UniProtKB/TrEMBL: Q76R61
TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324403(US10189835, Compound 434)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324405(US10189835, Compound 561)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324406(US10189835, Compound 587)
Affinity DataEC50: <1.00E+3nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324408(US10189835, Compound 599)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324409(US10189835, Compound 795)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324410(US10189835, Compound 796)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324411(US10189835, Compound 798)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324412(US10189835, Compound 800)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324413(US10189835, Compound 803)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324415(US10189835, Compound 805)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324416(US10189835, Compound 594)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324417(US10189835, Compound 595)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324418(US10189835, Compound 600)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324419(US10189835, Compound 695)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324421(US10189835, Compound 697)
Affinity DataEC50: <1.00E+3nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324422(US10189835, Compound 698)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324423(US10189835, Compound 699)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324424(US10189835, Compound 828)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324424(US10189835, Compound 828)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324425(US10189835, Compound 910)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324426(US10189835, Compound 912)
Affinity DataEC50: <500nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM324427(US10189835, Compound 937)
Affinity DataEC50: <100nMAssay Description:HBV replication inhibition by the compounds of this invention could be determined in cells infected or transfected with HBV, or cells with stably int...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2019
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM476239(US10874640, Compound 1)
Affinity DataEC50:  27.1nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400023(US10328053, Compound 2 | (R)-N-(3-chloro-4-fluorop...)
Affinity DataEC50:  15.9nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400024(US10328053, Compound 3 | N-(3-chloro-4-fluoropheny...)
Affinity DataEC50:  14.9nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400025(US10328053, Compound 4 | (1aS,6aS)-N-(3-chloro-4-f...)
Affinity DataEC50:  63.6nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM476243((1aR,6aR)—N-(3-chloro-4-fluorophenyl)-5-(2-((...)
Affinity DataEC50:  8.80nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM476244(7-(2-((1-(1H-1,2,3-Triazol-4-yl)cyclopropyl)amino)...)
Affinity DataEC50:  11.1nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400028(US10328053, Compound 7 | N-(3-chloro-4-fluoropheny...)
Affinity DataEC50:  5.80nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM476246(N-(3-chloro-4-fluorophenyl)-7-(2-((3,3-difluoro-1-...)
Affinity DataEC50:  72nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400029(US10328053, Compound 8 | N-(3-chloro-4-fluoropheny...)
Affinity DataEC50:  103nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400031(US10328053, Compound 10 | 7-(2-((1-((2-oxa-6-azasp...)
Affinity DataEC50:  56.1nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400032(US10328053, Compound 11 | N-(3-chloro-4-fluorophen...)
Affinity DataEC50:  7.70nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400033(US10328053, Compound 12 | 7-(2-((1-(1,3,4-thiadiaz...)
Affinity DataEC50:  5nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400034(US10328053, Compound 13 | N-(3-chloro-4-fluorophen...)
Affinity DataEC50:  252nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400035(US10328053, Compound 14 | N-(3-chloro-4-fluorophen...)
Affinity DataEC50:  8.80nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400036(US10328053, Compound 15 | N-(3-chloro-4-fluorophen...)
Affinity DataEC50:  45.8nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400037(US10328053, Compound 16 | (R)-N-(3-chloro-4-fluoro...)
Affinity DataEC50:  456nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400038(US10328053, Compound 17 | (R)-N-(3-chloro-4-fluoro...)
Affinity DataEC50:  64.5nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400039(US10328053, Compound 18 | N-(3-chloro-4-fluorophen...)
Affinity DataEC50:  33.2nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400040(US10328053, Compound 19 | N-(3-cyano-4-fluoropheny...)
Affinity DataEC50:  167nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM476258(N-(3-chloro-4-fluorophenyl)-3,6-dimethyl-7-(2-oxo-...)
Affinity DataEC50:  49.4nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM476259(N-(3-chloro-4-fluorophenyl)-6-methyl-7-(2-((3-meth...)
Affinity DataEC50:  20.1nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400044(US10328053, Compound 22 | US10874640, Compound 22 ...)
Affinity DataEC50:  37nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400045(US10328053, Compound 23 | US10874640, Compound 23 ...)
Affinity DataEC50:  66nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM476262(US10874640, Compound 24)
Affinity DataEC50:  43.7nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400047(US10328053, Compound 25 | US10874640, Compound 25 ...)
Affinity DataEC50:  408nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM400048(US10328053, Compound 26 | N-(3-chloro-4-fluorophen...)
Affinity DataEC50:  14.6nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM476265(N-(3-chloro-4-fluorophenyl)-7-(2-((3,3-difluoro-1-...)
Affinity DataEC50:  32.3nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

TargetCapsid protein(HBV-C)
Novira Therapeutics

US Patent
LigandPNGBDBM476266(N-(3-chloro-4-fluorophenyl)-7-(2-((3,3-difluoro-1-...)
Affinity DataEC50:  112nMAssay Description:A HepG2 cell line overexpressing the HBV virus attachment receptor sodium-taurocholate cotransporting polypeptide (NTCP) was grown to confluency in D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/25/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 216 total ) | Next | Last >>
Jump to: